Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Torley Helen (CIK 1528185) reported 160 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Buy HALO (20,000 shares), Sell HALO (13,304 shares), Sell HALO (6,596 shares), Sell HALO (100 shares), Buy HALO (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 13,304 | $1.4M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 6,596 | $711,187 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 100 | $10,867 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 14,588 | $1.6M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 5,412 | $582,228 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 15,492 | $1.7M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 4,508 | $484,826 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 500 | $50,228 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 900 | $89,062 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 2,100 | $213,709 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 9,000 | $922,977 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 7,500 | $776,115 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 5,703 | $587,882 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 4,897 | $509,827 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 9,400 | $985,816 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 7,200 | $765,778 |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 9,600 | $1.0M |
| 2026-08-19 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 3,200 | $344,848 |
| 2026-07-09 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 1,923 | $23,211 |
Source: SEC Form 4 filings · as of 2026-09-11